Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Bisoprolol 2.5mg Tablet – PA22654/002/001
- Candist 8mg Tablet – PA0126/206/002
- Candist 16mg Tablet – PA0126/206/003
- Co-Amoxiclav Teva 500/100mg Powder for Solution for Injection/Infusion – PA0749/011/001
- Irbesartan 75mg Tablet – PA0126/205/001
- Irbestartan 150mg Tablet – PA0126/205/002
- Paramax 500mg/5mg Tablet – PA0540/154/001
- Perdamel 0.5mg Tablet – PA0126/169/002
- Prosentio 100mg Tablet – PA0126/190/001
- Vepesid 50mg Capsule – PA2255/004/001
- Xanax 0.5mg Tablet – PA0822/141/003
- Zanaflex 2mg Tablet – PA0749/054/001
- Zanaflex 4mg Tablet – PA0749/054/002
The following shortage has been resolved and supply has resumed to the Irish market:
- Accupro 10mg Tablet – PA0822/007/002
- Clonactil 100mg Film Coated Tablet – PA0126/026/002
- Doxycycline Teva 100mg Hard Capsules – PA1986/081/001
- Solpadol Caplets 500mg/30mg Tablet – PA0540/159/001
- Solpadol Effervescent 500mg/30mg Tablet – PA0540/159/003
- Triapin 5mg/5mg Prolonged Release Tablet – PA0540/082/002
- Vancomycin 100mcg Powder for Concentrate for Solution for Infusion and Oral Solution – PA1122/008/002
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated in real time.